162 related articles for article (PubMed ID: 11127976)
21. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate.
Krupski T; Petroni GR; Frierson HF; Theodorescu JU
Urology; 2000 May; 55(5):743-9. PubMed ID: 10792093
[TBL] [Abstract][Full Text] [Related]
22. Endocrine differentiation of gastric adenocarcinoma. The prevalence as evaluated by immunoreactive chromogranin A and its biologic significance.
Ooi A; Mai M; Ogino T; Ueda H; Kitamura T; Takahashi Y; Kawahara E; Nakanishi I
Cancer; 1988 Sep; 62(6):1096-104. PubMed ID: 3044573
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine (ECL cell) differentiation of spontaneous gastric carcinomas of cotton rats (Sigmodon hispidus).
Waldum HL; Rørvik H; Falkmer S; Kawase S
Lab Anim Sci; 1999 Jun; 49(3):241-7. PubMed ID: 10403437
[TBL] [Abstract][Full Text] [Related]
24. Adenocarcinoma of female paraurethral duct showing neuroendocrine differentiation.
Islam AH; Kato H; Hayama M; Kobayashi S; Ota H; Nishizawa O
Urology; 2001 Dec; 58(6):1058. PubMed ID: 11744493
[TBL] [Abstract][Full Text] [Related]
25. Parathyroid hormone-related peptide expression in primary and metastatic liver tumours.
Roskams T; Willems M; Campos RV; Drucker DJ; Yap SH; Desmet VJ
Histopathology; 1993 Dec; 23(6):519-25. PubMed ID: 8314235
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
[TBL] [Abstract][Full Text] [Related]
27. Bcl2 expression and its correlation with neuroendocrine differentiation in colon carcinomas.
Atasoy P; Bozdoğan O; Oztürk S; Ensari A
Tumori; 2004; 90(2):233-8. PubMed ID: 15237588
[TBL] [Abstract][Full Text] [Related]
28. Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy.
Pruneri G; Galli S; Rossi RS; Roncalli M; Coggi G; Ferrari A; Simonato A; Siccardi AG; Carboni N; Buffa R
Prostate; 1998 Feb; 34(2):113-20. PubMed ID: 9465942
[TBL] [Abstract][Full Text] [Related]
29. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
Villari D; Caruso R; Grosso M; Vitarelli E; Righi M; Barresi G
Pathology; 2002 Oct; 34(5):423-6. PubMed ID: 12408340
[TBL] [Abstract][Full Text] [Related]
30. Nonspecificity of colon-specific antigen in adenocarcinomas. An immunohistochemical study of 422 cases.
Loy TS; Chapman RK; White L; Diaz-Arias AA; Bickel JT
Am J Clin Pathol; 1992 Apr; 97(4):490-2. PubMed ID: 1553913
[TBL] [Abstract][Full Text] [Related]
31. Signet ring cells in gastric carcinomas are derived from neuroendocrine cells.
Bakkelund K; Fossmark R; Nordrum I; Waldum H
J Histochem Cytochem; 2006 Jun; 54(6):615-21. PubMed ID: 16344325
[TBL] [Abstract][Full Text] [Related]
32. Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.
Kidd M; Modlin IM; Mane SM; Camp RL; Shapiro MD
Ann Surg; 2006 Feb; 243(2):273-80. PubMed ID: 16432362
[TBL] [Abstract][Full Text] [Related]
33. Gastric collision between a papillotubular adenocarcinoma and a gastrinoma in a patient with Zollinger-Ellison syndrome.
de Leval L; Hardy N; Deprez M; Delwaide J; Belaïche J; Boniver J
Virchows Arch; 2002 Nov; 441(5):462-5. PubMed ID: 12447676
[TBL] [Abstract][Full Text] [Related]
34. An immunohistochemical study of neuroendocrine cells in gynecologic tumors.
Ueda G; Shimizu C; Saito J; Inoue Y; Tanaka Y; Inoue M; Tanizawa O
Int J Gynaecol Obstet; 1989 Jun; 29(2):165-72. PubMed ID: 2568293
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine cells in diffuse gastric carcinomas: an ultrastructural study with immunogold labeling of chromogranin A.
Martinsen TC; Skogaker NE; Fossmark R; Nordrum IS; Sandvik AK; Bendheim MØ; Bakkelund KE; Waldum HL
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):62-8. PubMed ID: 19713831
[TBL] [Abstract][Full Text] [Related]
36. Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component.
Brouland JP; Manivet P; Brocheriou-Spelle I; Wassef M; Le Bodic MF; Lavergne A; Launay JM
Endocr Pathol; 2001; 12(1):77-86. PubMed ID: 11478272
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance.
Atasoy P; Ensari A; Demirci S; Kurşun N
Tumori; 2003; 89(1):49-53. PubMed ID: 12729362
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical demonstration of chromogranins A and B in neuroendocrine tumors of the lung.
Tötsch M; Müller LC; Hittmair A; Ofner D; Gibbs AR; Schmid KW
Hum Pathol; 1992 Mar; 23(3):312-6. PubMed ID: 1313391
[TBL] [Abstract][Full Text] [Related]
39. The incidence of chromogranin A defined endocrine cells decreases with tumour progression in gastric adenocarcinoma.
Ikeda Y; Mori M; Haraguchi Y; Sasaki O; Sugimachi K
Surg Oncol; 1995; 4(5):255-60. PubMed ID: 8850027
[TBL] [Abstract][Full Text] [Related]
40. Gastric carcinoma cells with endocrine differentiation show no evidence of proliferation.
Ooi A; Hayashi H; Katsuda S; Nakanishi I
Hum Pathol; 1992 Jul; 23(7):736-41. PubMed ID: 1351863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
